EYES - Second Sight Medical Products, Inc.
| Previous Close | 2.23 |
| Open | 2.23 |
| Bid | 2.17 x 900 |
| Ask | 2.18 x 800 |
| Day's Range | 2.14 - 2.25 |
| 52 Week Range | 0.90 - 2.58 |
| Volume | 206,727 |
| Avg. Volume | 437,493 |
| Market Cap | 142.594M |
| Beta | 1.75 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.53 |
| Earnings Date | Jul 30, 2018 - Aug 3, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.00 |
- ACCESSWIRE•2 days ago
Complimentary Technical Snapshots on Prestige Brands and Three More Medical Equipment Stocks
Stock Research Monitor: EYES, SENS, and VAR LONDON, UK / ACCESSWIRE / May 23, 2018 / If you want a free Stock Review on PBH sign up now at www.wallstequities.com/registration . Ahead of today's trading ...
- Business Wire•11 days ago
Second Sight Medical Products, Inc. to Present at the 19th Annual B. Riley FBR Investor Conference
Second Sight's mission is to develop, manufacture and market innovative implantable visual prosthetics to enable blind individuals to achieve greater independence. Second Sight has developed, and now manufactures and markets, the Argus® II Retinal Prosthesis System.
- Associated Press•15 days ago
Second Sight Medical Products: 1Q Earnings Snapshot
The Sylmar, California-based company said it had a loss of 17 cents per share. Losses, adjusted for one-time gains and costs, were 14 cents per share. The maker of camera-based retinal implants posted ...
- Business Wire•15 days ago
Second Sight Reports First Quarter 2018 Financial Results
Second Sight Medical Products, Inc. , a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today reported financial results for the three months ended March 31, 2018.
- Business Wire•18 days ago
Second Sight Completes $10 Million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors
Second Sight Medical Products, Inc. (EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today announced that it has entered into a stock purchase agreement on May 3, 2018 with entities beneficially owned by Gregg Williams for the purchase of 6,756,757 shares of common stock priced at $1.48 per share, the last reported sale price of the common stock on that date. Gregg Williams is Chairman of the Board of Directors of Second Sight. This placement of common stock is anticipated to yield gross proceeds of approximately $10 million to the Company and was completed without providing warrants or discounts and without incurring any placement agent or investment banking fees in connection with this transaction.
- Business Wire•22 days ago
Second Sight to Discuss First Quarter 2018 Financial Results on May 10, 2018 Conference Call
Second Sight Medical Products, Inc. (EYES), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind patients, will release its 2018 first quarter financial results on Thursday, May 10, 2018, after the close of the U.S. financial markets. Second Sight’s U.S. Headquarters are in Los Angeles, California, and European Headquarters are in Lausanne, Switzerland.
- GlobeNewswire•24 days ago
Research Report Identifies Flexsteel Industries, Second Sight Medical Products, XG Technology, CRA International, Inc, Neos Therapeutics, and Tech Data with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
NEW YORK, May 01, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Flexsteel ...
- Business Wire•2 months ago
Second Sight Announces Dr. Robert Greenberg’s Resignation from Board of Directors and as an Officer of the Company
Second Sight Medical Products, Inc. , a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today announced that Dr.
- Business Wire•2 months ago
Second Sight Appoints John T. Blake Chief Financial Officer
Second Sight Medical Products, Inc. , a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today announced that John T.
- GlobeNewswire•2 months ago
Research Report Identifies Anthera Pharmaceuticals, Hancock Holding, MKS Instruments, Second Sight Medical Products, Eclipse Resources, and Aircastle with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
NEW YORK, March 19, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
- Business Wire•2 months ago
Second Sight Appoints Gregg Williams as Chairman of the Board of Directors
Second Sight Medical Products, Inc. , a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today announced that the Board of Directors has appointed Mr.
- Business Wire•3 months ago
Second Sight Medical Products, Inc. to Present at the B. Riley & Co. China Healthcare Investment Partnering Symposium
Second Sight Medical Products, Inc. , a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today announced that Will McGuire, President and Chief Executive Officer, will present at the B.
- Associated Press•3 months ago
Second Sight Medical Products posts 4Q loss
On a per-share basis, the Sylmar, California-based company said it had a loss of 13 cents. Losses, adjusted for non-recurring gains, were 14 cents per share. The maker of camera-based retinal implants ...
- Business Wire•3 months ago
Second Sight Reports Fourth Quarter and Full Year 2017 Financial Results
Second Sight Medical Products, Inc. , a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today reported financial results for the three- and twelve-month periods ended December 31, 2017.
- ACCESSWIRE•3 months ago
Second Sight Medical Products, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / March 7, 2018 / Second Sight Medical Products, Inc. (NASDAQ: EYES ) will be discussing their earnings results in their Q4 Earnings Call to be held on March 7, 2018, at 4:30 ...
- Business Wire•3 months ago
Second Sight Announces Latest Expansion of Medicare Coverage for Argus II Retinal Prosthesis System
Second Sight Medical Products, Inc. , a developer, manufacturer and marketer of implantable visual prosthetics intended to create an artificial form of useful vision for blind individuals, today announced that Palmetto GBA is the latest Medicare Administrative Contractor to provide coverage for the Argus® II Retinal Prosthesis System and the related surgical procedure.
- Business Wire•3 months ago
Second Sight Medical Products, Inc. to Present at the Inaugural LD Micro Virtual Investor Conference on March 7, 2018
Second Sight Medical Products, Inc. , a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today announced that Dr.
- Business Wire•3 months ago
Second Sight to Discuss Fourth Quarter and Year-End 2017 Financial Results on March 7, 2018 Conference Call
Second Sight Medical Products, Inc. , a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind patients, will release its fourth quarter and year-end financial results on Wednesday, March 7, 2018, after the close of the U.S.
- Business Wire•3 months ago
Second Sight Announces Market Entry into Singapore with First Implant of Argus II Retinal Prosthesis System
Second Sight Medical Products, Inc. , a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind patients, today announced market entry into Singapore, with the first patient implanted with the Company’s Argus® II Retinal Prosthesis System .
- ACCESSWIRE•4 months ago
Second Sight Medical, Investors Open Their Eyes Making These Shares Soar, Recent Developments
NEW YORK, NY / ACCESSWIRE / February 7, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies, is issuing a comprehensive ...
SmarterAnalyst•4 months agoSecond Sight Medical Products Inc Execution Is Firing on All Cylinders Following Standout 4Q:17 Implants
The biotech company's lead product Argus II Retinal Prosthesis Systems vaulted to historically high implants during the fourth quarter. The bull had been playing it safe, betting on a conservative 18 Argus II implants in the span of the same period.
- Zacks•4 months ago
Second Sight (EYES) Catches Eye: Stock Jumps 12.7%
Second Sight (EYES) saw a big move last session, as its shares jumped nearly 13% on the day, amid huge volumes.
- Business Wire•4 months ago
Second Sight Announces Record Number of Argus II Retinal Prosthesis Systems Implants and Completes First-in-Human Orion Cortical Implant
Second Sight Medical Products, Inc. , a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today provided an update on several key performance metrics, demonstrating the Company’s continued progress in executing its near- and long-term goals.
- Simply Wall St.•4 months ago
High Growth Stocks To Invest In
Five Prime Therapeutics and Second Sight Medical Products are a few noticeable companies with a strong future outlook. The market’s optimistic sentiment towards these stocks indicates a level of confidenceRead More...
